LGC Capital Ltd. (TSXV:LG), a Canadian cannabis stock, jumped after announcing that Global Canna Labs has been approved to begin commercial medical cannabis sales in Jamaica
A sunny sales announcement was good news for more than a few Canadian cannabis stock investors Thursday. Here’s some small stocks making big moves on Thursday, April 4, 2019 (as of 4 pm EST):
LGC Capital Ltd. (TSXV:LG), a Canadian cannabis stock, climbed 30% to $0.13 on Thursday after announcing that is has been advised that Global Canna Labs has now received their formal approvals late in March from the Jamaican Cannabis Licensing Agency to commence commercial medical cannabis sales domestically to licensed dispensaries.
As well, shares of Canada Jetlines Ltd. (TSXV:JET) fell 12% to $0.52 as the pending ultra-low cost carrier airline said it has set a launch of commercial service targeted for December 17, 2019. The Company added that it and AerCap have mutually agreed to terminate the leases for two Airbus A320 aircraft, and Jetlines has entered into a letter of intent with its partner, SmartLynx Airlines SIA, for the lease of two alternate Airbus A320 that will be available for delivery in Q4 2019.
D-BOX Technologies Inc. (TSX:DBO), meanwhile, reported that it has signed another agreement to install recliner motion seats in Galaxy Theatres’ brand new state-of-the-art theatre in the Boulevard Mall in Las Vegas. D-BOX Technologies stock moved up 3% to $0.17 following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
LGC Capital Ltd. (TSXV:LG), a Canadian cannabis stock, climbed 30% to $0.13 on Thursday after announcing that is has been advised that Global Canna Labs has now received their formal approvals late in March from the Jamaican Cannabis Licensing Agency to commence commercial medical cannabis sales domestically to licensed dispensaries.
